ARCHIVES

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

This article is from The Cancer Letter archive.

Vol. 02 No. 28 | July 9, 1976

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Key In Long-Term Treatment

August 29, 2008

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

NCI To require Prompt Publication Of Data Affected By Falsification In Future Grants

April 8, 1994

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

Abortion, Miscarriage Don’t Increase Breast Cancer Risk, NCI Workshop Finds

March 7, 2003

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993